Learn more about NYSCF’s latest announcements, statements and research breakthroughs.
Human stem-cell-derived astrocytes can be triggered to become toxic to neurons, opening the door for new understanding and treatment of neurodegenerative diseases. Featured image credit: Christina...
Research teams will use stem cell and gene editing technologies to advance NK cell-based therapies for cancer New York, New York (January 9, 2020) – The...
First patient-derived, induced pluripotent stem cell disease-specific organoid models in microgravity to advance understanding of neurodegenerative disease LOUISVILLE, KY — (BUSINESS WIRE) — The National Stem...
Unmatched Scope of Resources Will Identify Distinctive Disease Mechanisms in Small Patient Subgroups, Supporting Development of Custom Therapeutic Approaches New York, NY (October 22, 2019) –...
New York, NY (October 22, 2019) – The New York Stem Cell Foundation (NYSCF) today announced the 2019 class of NYSCF – Robertson Investigators, welcoming six...
The New York Stem Cell Foundation’s (NYSCF) 14th Annual Conference convenes global leaders in stem cell research to present their latest progress towards new treatments and...
Four-year Study of over 500 Research Institutions Identifies Widespread Gender Imbalance New York, NY (September 5, 2019) – Teams from the New York Stem Cell Foundation...
Research team finds that mesenchymal progenitors can be grown without use of animal-derived compounds New York, NY (January 14, 2019) – A team of scientists from...
Research teams will use stem cell and gene editing technologies to advance cell-based therapies for devastating diseases New York, New York (January 9, 2019) – The...
NEW YORK, NY (October 23, 2018) – The New York Stem Cell Foundation (NYSCF) announced the 2018 class of NYSCF – Robertson Investigators, welcoming six of...
MEDIA ADVISORY The New York Stem Cell Foundation Conference When: Tuesday and Wednesday, October 23rd– 24th, 2018 8:30AM – 5:30PM Where: The Rockefeller University, Caspary Auditorium...
Scientific teams will develop advanced stem cell models to improve understanding and treatment of Parkinson’s, Alzheimer’s, and similar diseases New York, NY (September 12, 2018) –...
New collaboration aims to develop better therapies New York, NY (August 1, 2018) – The New York Stem Cell Foundation (NYSCF) Research Institute today announced a...
Protocol adds a new cell type enabling myelination in human ‘mini-brains’ for laboratory research New York, NY (July 25, 2018) – In a collaborative study between...
Scientists from the New York Stem Cell Foundation (NYSCF) Research Institute have developed a new bone engineering technique called Segmental Additive Tissue Engineering (SATE). The technique,...
Two top scientific and business professionals recently joined NYSCF, bolstering its leadership team: Melissa J. Nirenberg, MD, PhD, FAAN has joined NYSCF as its inaugural Chief...
NYSCF welcomed six of the most talented stem cell researchers and neuroscientists from around the world into the NYSCF Investigator Program and the NYSCF Innovator Community....
Dr. Paul Tesar, a professor at Case Western Reserve University and NYSCF — Robertson Stem Cell Investigator Alumnus, is the 2017 recipient of the NYSCF –...
NYSCF and the Beyond Batten Disease Foundation (BBDF) partnered to create a unique and comprehensive collection of juvenile Batten (CLN3) disease induced pluripotent stem (iPS) cells....
Your body is full of immune cells that fight off infection and illness. You’ve probably heard of a few of them: white blood cells, B cells,...
NYSCF officially opened its new state-of-the-art Research Institute and headquarters in Manhattan. The expanded NYSCF Research Institute will allow scientists to conduct the most advanced stem...
A collaboration beginning in 2013 between the NYSCF Research Institute and the Personal Genome Project (PGP) has resulted in the availability of a unique new stem...
A team of researchers at Columbia University Medical Center including NYSCF – Robertson Investigator Dr. Dieter Egli have discovered that a specific enzyme deficiency in the brain...
Leaders in stem cell biology and researchers at the forefront of translational medicine convened at the 2016 NYSCF Conference to discuss the latest advances in using...
NYSCF announced today that Feng Zhang, PhD, is the 2016 recipient of the NYSCF – Robertson Stem Cell Prize for his pioneering advances to edit human...
